Cargando…

Chasing the Zebra: a case of membranous-like Glomerulopathy with SSA/RO52 deposits and no overt connective tissue disease

BACKGROUND: The nature of the deposits in immune-mediated glomerulonephritis with a membranous pattern and masked IgG-Kappa deposits (MGMID) remains still to be elucidated. CASE PRESENTATION: We present a case of 33-year-old woman developing a continuous asymptomatic proteinuria (0.8–1 g/24 h) with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sciascia, Savino, Miraglia, Paolo, Radin, Massimo, Giarin, Manuela, Charbonier, Nicolas, Barreca, Antonella, Cecchi, Irene, Lanzetta, Irene, Fenoglio, Roberta, Menegatti, Elisa, Roccatello, Dario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074652/ https://www.ncbi.nlm.nih.gov/pubmed/37016425 http://dx.doi.org/10.1186/s41927-023-00330-1

Ejemplares similares

Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience
por: Sciascia, Savino, et al.
Publicado: (2022)

Genetic Factors in Antiphospholipid Syndrome: Preliminary Experience with Whole Exome Sequencing
por: Barinotti, Alice, et al.
Publicado: (2020)

Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies
por: Radin, Massimo, et al.
Publicado: (2021)

Finding the Needle in the Haystack: Serological and Urinary Biomarkers in Behçet’s Disease: A Systematic Review
por: Arbrile, Marta, et al.
Publicado: (2023)

Renal involvement as a unique manifestation of hemophagocytic syndrome
por: Roccatello, Dario, et al.
Publicado: (2022)

The Ro/SSA autoantigen as an immunogen. Some anti-Ro/SSA antibody binds IgG
Publicado: (1986)

The “4 plus 2” rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study
por: Roccatello, Dario, et al.
Publicado: (2017)

New Frontiers in Autoimmune Diagnostics: A Systematic Review on Saliva Testing
por: Foddai, Silvia Grazietta, et al.
Publicado: (2023)

Renal Fibrosis in Lupus Nephritis
por: Sciascia, Savino, et al.
Publicado: (2022)

Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab
por: Sciascia, Savino, et al.
Publicado: (2023)

IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients
por: Sciascia, Savino, et al.
Publicado: (2019)

Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation
por: Radin, Massimo, et al.
Publicado: (2021)

Serum Biomarkers of Renal Fibrosis: A Systematic Review
por: Barinotti, Alice, et al.
Publicado: (2022)

Detection of Autoantibodies in Saliva as New Avenue for the Diagnosis and Management of Autoimmune Patients
por: Sciascia, Savino, et al.
Publicado: (2022)

The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents
por: Roccatello, Dario, et al.
Publicado: (2017)

Vedolizumab for the Management of Refractory Behçet’s Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease
por: Arbrile, Marta, et al.
Publicado: (2021)

The need for kidney biopsy in the management of side effects of target and immunotherapy
por: Fenoglio, Roberta, et al.
Publicado: (2023)

Anti-Ro/SSA antibodies in rheumatoid arthritis (RA)
por: Franceschini, F, et al.
Publicado: (2003)

Clinical and Pathological Roles of Ro/SSA Autoantibody System
por: Yoshimi, Ryusuke, et al.
Publicado: (2012)

Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies
por: Sciascia, Savino, et al.
Publicado: (2021)

Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome
por: Fenoglio, Roberta, et al.
Publicado: (2018)

Focal segmental glomerular sclerosis can be effectively treated using an intensive B-cell depletion therapy
por: Roccatello, Dario, et al.
Publicado: (2022)

Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study
por: Sciascia, Savino, et al.
Publicado: (2021)

Anti-Ro/SSA Antibodies and the Autoimmune Long-QT Syndrome
por: Lazzerini, Pietro Enea, et al.
Publicado: (2021)

Severe Multi-Organ Failure and Hypereosinophilia: When to Call It “Idiopathic”?
por: Radin, Massimo, et al.
Publicado: (2018)

CD38 and Anti-CD38 Monoclonal Antibodies in AL Amyloidosis: Targeting Plasma Cells and beyond
por: Roccatello, Dario, et al.
Publicado: (2020)

Recognizing the new disorder “idiopathic hypocryoglobulinaemia” in patients with previously unidentified clinical conditions
por: Roccatello, Dario, et al.
Publicado: (2022)

Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies
por: Radin, Massimo, et al.
Publicado: (2020)

Possible role of anti-SSA/Ro antibodies in the pathogenesis of pulmonary hypertension
por: Guerreso, Kelsey, et al.
Publicado: (2016)

Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay
por: Sciascia, Savino, et al.
Publicado: (2016)

Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study
por: Sciascia, Savino, et al.
Publicado: (2019)

Zebra Hunting: How Caring Is Lost When We Chase Diseases
por: Allan-Blitz, Lao-Tzu
Publicado: (2020)

Comparison of different methods for the detection of the fine specificity of anti-Ro/SSA response
por: Cavazzana, I, et al.
Publicado: (2001)

Isolated anti-Ro/SSA thrombocytopenia: a rare feature of neonatal lupus
por: Ayadi, Imene Dahmane, et al.
Publicado: (2015)

Neuromyelitis optic with positive Anti-AQP4 and Anti-SSA/Ro antibody
por: Estiasari, Riwanti, et al.
Publicado: (2019)

Anti-Ro/SSA Antibodies May Be Responsible for Cerebellar Degeneration in Sjogren’s Syndrome
por: Tetsuka, Syuichi, et al.
Publicado: (2021)

High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review: High levels of anti-SSA/Ro antibodies in COVID-19
por: Fujii, Hiroyuki, et al.
Publicado: (2020)

Long-term effects of intensive B cell depletion therapy in severe cases of IgG4-related disease with renal involvement
por: Quattrocchio, Giacomo, et al.
Publicado: (2020)

Recent advances in the management of systemic lupus erythematosus
por: Sciascia, Savino, et al.
Publicado: (2018)

Common and Specific Associations of Anti-SSA/Ro60 and Anti-Ro52/TRIM21 Antibodies in Systemic Lupus Erythematosus
por: Menéndez, Aurora, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_665qm1stefisb4qffiqoq6iauc